We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Selpercatinib is a selective targeted therapy designed to inhibit abnormal RET signaling. Its full approval confirms its role as a tumor-agnostic ..."
"The U.S. Food and Drug Administration (FDA) has granted full approval to selpercatinib, marketed as Retevmo, for the treatment of patients aged 2 ..."
"It is a powerful motivator to see discoveries in my lab over 3 decades culminate in FDA approval of ONC201/dordaviprone less than a year ago in ..."
"Concordantly, a concurrent neck MRI demonstrated bone metastases in the vertebrae and sternum, with no evidence of local tumor recurrence in the ..."
"... thyroid cancer, and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer. The Company's other two products are COTELLIC, an ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.